Sep 13, 2022 ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer
Jul 27, 2022 ProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conference
Jun 22, 2022 ProMIS Neurosciences Announces Filing of Form 10 Registration Statement and Nasdaq Listing Application